Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06370182 · ClinicalTrials.gov registry record · NA
Safety and Effectiveness of Mechanical Thrombectomy Using the Anaconda ANA Funnel Catheter
A NA study of Acute Ischemic Stroke From Large Vessel Occlusion, sponsored by Anaconda Biomed S.L..
- Recruiting
- Registry status
- NA
- Development phase
- 327
- Enrollment target
- 20
- Study locations
NCT06370182 is a NA study of Acute Ischemic Stroke From Large Vessel Occlusion that is actively recruiting participants, run by Anaconda Biomed S.L.. The registered enrollment target is 327 participants. The trial reports 20 study locations across 11 states.
The verdict
NCT06370182, a NA study of Acute Ischemic Stroke From Large Vessel Occlusion, is actively recruiting participants, sponsored by Anaconda Biomed S.L..
- RECRUITING
- Registry status
- NA
- Development phase
- 327 participants
- Enrollment target
- 20
- Study locations
Study Summary
The objective of this study is to assess the safety and effectiveness of mechanical thrombectomy (MT) using the ANA funnel catheter in its intended use, which is to facilitate the navigation and deployment of other neurovascular devices and to allow flow arrest during mechanical thrombectomy procedures performed in subjects experiencing acute ischemic stroke (AIS) secondary to large vessel occlusion (LVO) and treated within 24 hours of symptom onset.
Conditions Studied
Interventions
- DEVICE Control
- DEVICE ANA Funnel Catheter
Study Locations (20)
Other
- Centre Hospitalier Universitaire de Montpellier - Montpellier
- Fondation Rothschild - Paris
- Hospital Foch - Suresnes
- Centre Hospitalier Universitaire de Toulouse - Toulouse
- Semmelweis University Hospital - Budapest
- Hospital Universitario Vall D'Hebron - Barcelona
- Hospital Clinic de Barcelona - Barcelona
- Hospital Clinico San Carlos - Madrid
- Hospital Virgen de la Arrixaca - Murcia
New York
- University of Buffalo Neurosurgery - Buffalo
- Mount Sinai Hospital - New York
Florida
- Baptist Health Medical Center - Jacksonville
Georgia
- Grady Memorial Hospital, Emory - Atlanta
Illinois
- Advocate Health - Park Ridge
Iowa
- University of Iowa - Iowa City
Massachusetts
- Boston Medical Center - Boston
Oregon
- Oregon Health & Science University - Portland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 327 participants |
| Start Date | 2024-09-09 |
| Est. Completion | 2027-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06370182
The ClinicalTrials.gov registry entry for NCT06370182 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 327 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Anaconda Biomed S.L., which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Acute Ischemic Stroke From Large Vessel Occlusion appearing as the primary indexed condition, and to 2 interventions - of which Control is the first listed.
NCT06370182 reports 20 study locations spanning 11 distinct geographic areas - top geographies include Other, New York, Florida.
Frequently Asked Questions
What is clinical trial NCT06370182 about?
NCT06370182 is a clinical study titled "Safety and Effectiveness of Mechanical Thrombectomy Using the Anaconda ANA Funnel Catheter". The objective of this study is to assess the safety and effectiveness of mechanical thrombectomy (MT) using the ANA funnel catheter in its intended use, which is to facilitate the navigation and deployment of other neurovascular devices and to allow flow arrest during mechanical thrombectomy procedu...
What is the current status of trial NCT06370182?
This trial is currently recruiting. It is a NA study. The enrollment target is 327 participants. The study started on 2024-09-09. Estimated completion is 2027-12.
What conditions does trial NCT06370182 study?
This clinical trial studies the following conditions: Acute Ischemic Stroke From Large Vessel Occlusion.
What interventions are being tested in trial NCT06370182?
The interventions under investigation include: Control (DEVICE), ANA Funnel Catheter (DEVICE).
Who is sponsoring clinical trial NCT06370182?
This trial is sponsored by Anaconda Biomed S.L., which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06370182 being conducted?
This trial has 20 study locations across Florida, Georgia, Illinois, Iowa, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acute Ischemic Stroke From Large Vessel Occlusion
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.